Palliative Radiotherapy With Lurbinectedin in Patients With Extensive Stage Small Cell Lung Cancer
Phase 1
22
about 5 years
18+
3 sites in GA
What this study is about
This trial is testing if it is safe to use palliative radiotherapy and lurbinectedin at the same time to treat small cell lung cancer that has spread outside of the chest. It aims to determine if this combination treatment works better than either one alone or causes more side effects.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Palliative Radiation Therapy
- 2.Take Lurbinectedin
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
lurbinectedin
injection, intravenous
Primary: Incidence of adverse events of palliative radio therapy (RT) with lurbinectedin
Secondary: Overall survival (OS), Pain response rates, Patient-reported toxicity, Progression free survival (PFS), Response rate
radiation